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Abstract
A simple, rapid and sensitive spectrophotometric method has been developed for the assay of ceterizine hydrochlo-
ride (CTZH) in bulk drug and its pharmaceutical preparations. This method is based on the ion-pair complex reaction
between CTZH and Alizarin Red S in Clarks–Lubs buffer. The chromogen being extractable with chloroform, could
be measured quantitatively at 440 nm. All variables were studied to optimise the reaction conditions. Regression
analysis of Beer’s Law plot showed good correlation in the concentration range 2.5–22 mg ml1. The method has a
detection limit of 0.1328 mg ml1. The proposed method has been successfully applied for the analysis of the bulk
drug and its dosage forms such as tablets and syrups. No interference was observed from common pharmaceutical
adjuvants. © 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Ceterizine hydrochloride, CTZH, (2-(4-(4-
chlorophenyl) phenylmethyl)-1-piperazinyl)-
ethoxy)-acetic acid dihydrochloride is a new
antihistaminic drug [1–3], currently marketed in
India under the trade names cetzine, zyncet,
zyrtec, cetrizet and cetiriz. It is indicated for the
treatment of perennial and seasonal allergetic
rhinitis and also for chronic uticaria. Currently,
CTZH and its formulations are not to be found in
any pharmacopoeia. Only two gas-chromato-
graphic methods [4,5] and three high performance
liquid chromatography (HPLC) methods [6–8]
have been described for the determination of ce-
terizine in biological materials. Recently [9], El-
Walily et al. have reported derivative
spectrophotometric and HPLC methods for the
determination of CTZH in pharmaceutical
tablets. No methods based on colour formation
have been reported for CTZH.
This paper describes a spectrophotometric
method based on ion-association complex forma-
tion between CTZH and the acid dye, Alizarin
Red S in Clarks–Lubs buffer of pH 3.2 (Fig. 1).
The proposed method is simple, sensitive and the
complex formed is stable for more than 24 h.
* Corresponding author. Tel.: 91-821-421-263; fax: 91-
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2. Experimental
2.1. Apparatus
An Elico Model SL 171 digital spectrophoto-
meter with 1-cm matched glass cells was used for
the absorbance measurements. pH measurements
were made with an Elico Model L1-120 digital pH
meter, calibrated with buffer solution (pH 49
0.05).
2.2. Chemicals and reagents
All chemicals and reagents were of analytical
grade. CTZH 99.62% purity (UNI-UCB, Mum-
bai, India) was used as the working standard.
Alizarin Red S ARS (s.d. Fine Chemicals) was
0.05% w:v in Clarks–Lubs buffer of pH 3.2.
Clarks–Lubs buffer of pH 3.2 was prepared by
mixing 125 ml of 0.1 M potassium hydrogen
phthalate and 36.75 ml of 0.1 M HCl and diluting
to 250 ml. Spectroscopic grade chloroform was
used.
Dosage forms used in this investigation were:
cetzine tablets and syrup (Glaxo Lab); cetiriz
tablets and syrup (Alchem Labs); zyncet tablets
and suspension (Unichem India); cetrizet-D
tablets (Sunpharm); alerid tablets and syrup (Ci-
pla); Zyrtec tablets (UNI-UCB) and zirtin tablets
(Torrent Pharm).
2.3. Preparation of standards
Twenty mg of CTZH, accurately weighed, were
transferred into a 100 ml volumetric flask, dis-
solved in water and completed to volume with the
same solvent. This solution was diluted appropri-
ately to get a working solution of 50 mg ml1.
2.4. Assay procedure
Aliquots of solution containing 2–22 mg ml1
of CTZH were transferred into a series of 125 ml
of separating funnels; then 5 ml of Clarks–Lubs
buffer of pH 3.2 and 2 ml of 0.05% ARS were
added. The total volume was adjusted to 15 ml by
adding distilled water. Chloroform (10 ml, accu-
rately measured) was added to each separating
funnel and the contents were shaken for exactly 1
min. The two phases were allowed to separate and
the chloroform layer was passed through anhy-
drous sodium sulphate and the absorbance was
measured at 440 nm against the reagent blank.
The reagent blank was prepared exactly like the
procedure described above, but in the absence of
CTZH. A calibration graph was drawn or regres-
sion equation calculated.
2.5. Assay procedure for tableted dosage
Tablets: twenty tablets were weighed and pow-
dered. An amount of the powder equivalent to 20
mg of antiallergic drug was weighed into a 100 ml
volumetric flask, 60 ml of distilled water were
added and shaken thoroughly for about 20 min.
The contents were diluted to the mark, mixed well
and filtered through a quantitative filter paper
(Whatman 40) to remove the insoluble matter
remaining. Twenty five ml of this filtrate was
Fig. 1. Structure of (a) ceterizine dihydrochloride; (b) Alizarin
Red S.
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Fig. 2. Absorption spectra of (a) ceterizine (CTZ)–ARS complex; (b) reagent blank.
diluted to 100 ml and a suitable aliquot was taken
for analysis using the procedure described earlier.
2.6. Syrup and suspension
In respect of syrup and suspension, 20 ml
equivalent to 20 mg of drug were transferred into
a 250 ml separator. The sample was rendered
alkaline to litmus with 6 N ammonia solution and
1 ml in excess was added. The mixture was then
extracted with 315 ml portions of chloroform,
the chloroform extracts were evaporated to dry-
ness and the residue was dissolved in 0.1 N HCl
and made upto 100 ml with distilled water. This
solution was diluted to get 50 mg ml1 of drug
and an aliquot was analysed as above.
3. Results and discussion
Ion-pair extraction spectrophotometry has re-
ceived considerable attention for quantitative esti-
mation of many pharmaceutically important
compounds [10–14]. CTZH reacted with ARS in
an acidic buffer to form a yellow ion-pair complex
which was extracted into chloroform. This com-
plex has an absorption maximum at 440nm
against reagent blank, hence this wavelength was
used for all subsequent measurements. Under the
same experimental conditions the reagent blank
gave negligible absorbance (Fig. 2).
3.1. Optimum conditions for complex formation
The optimum conditions for quantitative deter-
mination of the associated ion-pair formed were
established via a number of preliminary experi-
ments. The effect of pH was studied by extracting
the coloured complex formed in the presence of
various buffers of different acidic pH values. Of
the various buffers tried, Clark–Lubs (pH 2.2–
3.8) was found to be more suitable compared to
Walpole or Sorenson buffer in terms of sensitiv-
ity. In order to establish the optimum pH range,
CTZH was mixed with ARS in selected buffer of
pH 2.2–3.8, and the absorbance of the ion-associ-
ated complex was measured. Fig. 3 shows that the
absorbance increases and reaches a maximum and
a constant value at 3.0–3.4 pH range. At pH
values greater than 3.4, the decrease in ab-
sorbance of the complex and increase in ab-
sorbance of the blank were observed. Hence, a pH
of 3.2 was used in all subsequent experimental
work. The shape of the absorption spectrum and
maximum position did not vary with pH, so, it
was concluded that only one complex was formed
in this pH range.
K. Basa6aiah et al. : Talanta 50 (1999) 887–892890
The optimum volume of the dye used was also
studied. Fig. 4 revealed an increase in the ab-
sorbance readings with the increase of volume of
ARS upto 3.0 ml. However, a significant increase
in the absorbance value of the blank was observed
at volumes larger than 3 ml. Therefore, 3 ml of
0.05% w:v ARS was found to be quite adequate
in a total volume of 15 ml of aqueous phase.
Several organic solvents were tried to provide an
effective extraction of the drug-dye complex from
the aqueous phase and chloroform was preferred
for its selective extraction. A ratio of 3:2 of
aqueous to chloroform phases was required for
efficient extraction of the coloured species. Shak-
Fig. 3. Effect of pH on the absorbance of the ceterizine hydrochloride (CTZH)–ARS complex (final concentration of CTZH was
10 mg ml1).
Fig. 4. Effect of concentration of ARS (final concentration of ceterizine hydrochloride, CTZH, was 10 mg ml1).
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Table 1
Analysis of pharmaceutical preparations containing ceterizine hydrochloride (CTZH) by the proposed method
Preparation* Recovery by the proposed method (%)Label claim (mg tablet1 or ml1) RSD (%)
97.5810 1.32Ceterzine tabletsa
103.26Cetzine syrupa 0.841
98.3510 1.06Cetiriz tabletsb
1Cetiriz syrupb 97.64 0.95
102.1410 0.72Zyncet tabletsc
96.58Zyncet suspensionc 0.641
98.4210 0.26Cetrizet-D tabletsd
10Alerid tabletse 97.95 0.52
98.121 0.75Alerid syrupe
10Zyrtec tabletsf 101.54 0.68
10Zirtin tabletsg 98.73 1.26
* Marketed by: a, Glaxo Lab; b, Alchem; c, Unichem; d, Sun Pharmaceuticals; e, Cipla; f, UNI-UCB; g, Torrent Pharmaceuticals.
ing times of 0.5–5 min produced a constant ab-
sorbance, and hence a shaking time of 1 min was
used throughout. Only one extraction was ade-
quate to achieve a quantitative recovery of the
complex. Absorbances of the separated extracts
were stable for more than 24 h. The drug-dye
ratio as evaluated from the slope-ratio method
was 1:2.
3.2. Quantification
A linear correlation was found between ab-
sorbance and concentration of CTZH in the range
2–22 mg ml1. The equation for one representa-
tive calibration curve is:
A440 (0.0115 (0.035)C), where A and C cor-
respond to absorbance and CTZH concentration
in mg ml1, respectively. The correlation coeffi-
cient, r0.9995 (n8), indicates excellent linear-
ity. The molar absorptivity coefficient was
1.60104 l mol1 cm1, and Sandell sensitivity
was 0.3019 ng cm2. The method has a detection
limit of 0.1328 mg ml1.
The precision of the proposed method was ex-
cellent as indicated from the relative standard
deviation (S.D.B1%) calculated from eight repli-
cate analysis of 10 mg ml1 of pure CTZH.
3.3. Application
The applicability of the method to the assay of
dosage forms was examined by analysing tablets,
syrups and suspension marketed under different
trade names. Table 1 shows the quantities ob-
tained by the proposed method and labelled
amount. The relative S.D.s are lower than 1%
indicating good precision and the independence of
the matrix effect over the absorbance. The
method is simple and inexpensive as compared to
the currently available methods [4–9] which are
tedious and involve expensive experimental set-up
which ordinary laboratories cannot afford.
Acknowledgements
The authors thank M:s UNI-UCB Ltd., Mum-
bai, India, for gifting pure sample of ceterizine
hydrochloride.
References
[1] E. Balter, J. de Lannoy, R.L. Rodriguez, Eur. Pat. Appl.
EP 58146 A, Aug 18, 1982.
[2] J.P. Rihoux, C. De Vos, E. Balter, J. de Lannoy, Ann.
Allergy 55 (1985) 392.
[3] C. De Vos, M.R. Malleux, E. Balter, J. Gobert, Ann.
Allergy 55 (1985) 396.
[4] B. Eugene, C. Rene, B. Leon, G. Jean, J. Chromatogr.
430 (1988) 149.
[5] E. Balter, R. Coupez, L. Browers, J. Gobert, J. Chro-
matogr. 430 (1988) 74.
[6] M.T. Rossel, R.A. Lefebvere, J. Chromatogr. 561 (1991)
504.
[7] J. Moncrieff, J. Chromatogr. 583 (1992) 128.
K. Basa6aiah et al. : Talanta 50 (1999) 887–892892
[8] M.V. Suryanarayana, B.P. Reddy, G.L.D. Kru-
padanam, S. Venkataraman, C.S.P. Sastry, Indian
Drugs 29 (1992) 605.
[9] A.F.M. El Walily, M.A. Korany, A. El Gindy, M.F.
Bedair, J. Pharm. Biomed. Anal. 17 (1998) 435.
[10] C.S.P. Sastri, K. Rama Rao, D. Siva Prasad, Talanta
42 (1995) 311.
[11] J.C. Botello, G. Perez-Caballero, Talanta 42 (1995)
105.
[12] K. Basaviah, G. Krishnamurthy, Talanta 46 (1998)
665.
[13] O.H. Abdelmageed, P.Y. Khashava, Talanta 40 (1993)
1289.
[14] Tadao Sakai, Noriko Ohno, Talanta 33 (1986) 415.
.
